How Does Aevis Victoria Company Reach Customers and Turn Demand into Sales?

AEVIS VICTORIA SA focuses on privately or semi-privately insured Swiss patients who make up about 20% of the population but contribute a disproportionate share of surgical margins; the Swiss Medical Network clinics target these patients with concierge care pathways, shorter waits, and premium rooms to increase revenue per case. Aevis Victoria customer acquisition emphasizes partnerships with insurers and specialist referral networks to capture high-margin procedures.

In hospitality, AEVIS VICTORIA SA targets ultra-high-net-worth individuals and international luxury tourists seeking Swiss stability and privacy; average daily rates in top properties aim above typical Swiss averages to match expectations. Through the Nescens brand, the group targets global consumers in longevity and preventative medicine willing to pay premium out-of-pocket fees for anti-aging treatments and personalised programs, supporting direct-pay revenue streams and cross-selling between clinics and hotels.

AEVIS VICTORIA SA positions itself as a premium healthcare and hospitality integrator delivering Swiss quality, discretion, and clinical excellence; pricing and distribution channels reflect that stance, with emphasis on direct bookings, selected OTAs for luxury travel distribution, and B2B contracts with insurers and corporates. Aevis Victoria sales strategy and Aevis Victoria distribution channels prioritize direct channels and strategic partnerships for higher margin conversion.

The common thread is customers with high price inelasticity who value Swiss safety, confidentiality, and clinical outcomes; that supports higher average revenues per booking and lower sensitivity to seasonal discounts. Tactics include website optimization to improve conversion rates, targeted social media and email marketing campaigns, CRM-driven repeat sales, and revenue management to boost occupancy and surgical throughput. For ownership context see Ownership and Control of Aevis Victoria Company.

AEVIS VICTORIA SA uses direct sales via in-house clinical teams and hotel front desks, partner-led referrals (medical networks, insurers, OTAs), and channel sales to corporates and travel agents to capture demand across patient and guest segments.

Healthcare pricing is anchored in Swiss TARMED and DRG tariffs, supplemented by private upgrades and elective procedures; hotels use dynamic room rates, package bundles, and high-margin F&B and spa services to monetize each booking.

Conversion relies on vertical capture of the patient pathway (diagnosis to post-op), trust from specialist clinicians, dynamic revenue management for rooms, and cross-selling where medical tourists are directed to luxury recovery stays – non-room spend can exceed 40% of hotel revenue.

Retention comes from follow-up care, loyalty and corporate contracts; upsell levers include private-room upgrades, elective procedures, gastronomy, spa packages, and event/conference bookings that raise lifetime value per patient or guest.

AEVIS VICTORIA customer acquisition benefits from scale in Swiss healthcare and hospitality, growing outpatient care demand from an aging population, and a 2025 EBITDA margin of 16.5 percent that freed cash for targeted marketing and debt reduction.

Distribution channels blend direct booking, OTA partnerships, corporate B2B sales and local outreach; website and mobile booking optimization plus targeted email and social campaigns increase conversion and support Aevis Victoria sales strategy execution.

Key risks: Swiss Franc appreciation reducing inbound tourism demand, hospitality exposure to cyclical travel trends, and execution risk in scaling the Integrated Care capitation model in Jura which could delay revenue conversion.

Outlook is stable for 2025/2026: revenue management and cross-selling across healthcare and hospitality should sustain occupancy and ARPAR gains while the transition to a pure – play investment holding with high-quality real estate provides a valuation floor.